Pharmacodynamics of aztreonam/ceftazidime/avibactam and polymyxin B versus New Delhi MBL-producing Acinetobacter baumannii
This study supports the potential utility of low-dose PMB therapy in combination with β-lactams to combat NDM-producing CRAB.
Authors
- Anant P. Shah
- Jacob T. Dumbleton
- Brian M. Ho (ORCID: https://orcid.org/0000-0003-1533-6263)
- Harriet de Souza
- Nicholas M. Smith (ORCID: https://orcid.org/0000-0002-0212-2787)
- Navaldeep Singh
Institutions
- University at Buffalo, State University of New York (US)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1093/jacamr/dlaf068
- Citations
- 3
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases